SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Ostroski who wrote (5519)2/19/1998 7:03:00 AM
From: blankmind  Read Replies (2) of 23519
 
- Script data is fine.

- The percentages are from the previous week's numbers. So if Vivus is doing $120 mill a year; then any increase is great news. In fact, 7.4% increase on new scripts - is wonderful.

- Also, the American market is only one market. Multiply VVUS's success to 180 other countries - realizing that some will be flops and others more successful - and that's where the potential lies. In fact, that's how all the other drug companies got to be so darn big.

- Out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News